Pfizer Acquires Bamboo Therapeutics To Beef Up Gene Therapy Arsenal
Aviation fuel, the fuel that powers airplanes through the sky, is a special type of petroleum-based fuel. But just as we see many different pollution-related issues through the use of gasoline for vehicles, aviation fuel also emits a lot of pollution. In an attempt to remedy this situation, Boeing and a team of experts are working to develop a new kind of fuel for airplanes. Hard at work, they are hoping to develop biofuels that are capable of fueling airplanes! EnviroCitizen.org dug a little deeper to learn more about how and why.
The team developing this fuel is still working on refining the process. They are experimenting with different blends of biofuel sources, such as jatropha, algae and camelina. Jatropha, a family of plants native to Central America, has been used to make biodiesel fuel in the Philippines and Brazil. Camelina is a crop with high oil content, which has been used to produce vegetable oil. Algae, which many of us are familiar with, is a great source of energy because it yields a high amount of oil annually.
Working to refine and develop this school is a wonderful step forward. The fact that the airline industry is joining the green movement is a sign that environmentalists are going to see some real change soon. This biofuel will provide a more energy-efficient fuel with lower emissions. It will also help to make fuel costs more stable, which will enhance the quality of service throughout the airline industry.
20 years bricklaying "seniority" Master Li said, when the renovation had just begun, there are some families like to play with the terrazzo floor, terrazzo prices because the relatively low amount of random, colors and patterns can also be free play. However, the terrazzo construction is sometimes inconvenient, grinding process of water big, noisy, and later gradually abandoned by family decoration.
Bamboo was formed in 2014 to advance the work of Dr. Richard Jude Samulski, who is considered a pioneer in the field after he became the first to realize the potential of using adeno-associated virus's (AAV) as a vehicle to replace a defective gene with a healthy gene.
The collection, reputed to be the greatest lineup of modern masterpieces outside of Europe and the United States, includes major works by Pablo Picasso, Joan Miro, Andy Warhol, Jackson Pollock, Mark Rothko and Francis Bacon.
Since the Islamic revolution of 1979 that overthrew shah Mohammad Reza Pahlavi, the works assembled under the patronage of his wife Farah Pahlavi have not been shown together outside Iran before, according to the SPK.
"Sienna, Orange black on Dark Brown" by Mark Rothko is on display at Tehran's Museum of Contemporary Art (TMOCA) and is part of a collection bought in the 1970s by Farah Pahlavi ©Atta Kenare (AFP/File)
Aug 1 (Reuters) - Pfizer Inc said it had acquired privately held gene therapy developer Bamboo Therapeutics Inc in a deal worth up to $645 million to boost its presence in the treatment of rare diseases.
When you beloved this short article and you would want to receive details regarding Rickdesign.Ca i implore you to pay a visit to our own site. The U.S. Food and Drug Administration has yet to approve any gene therapies but Europe has approved two - a treatment from GlaxoSmithKline for a rare immune disorder in babies and one from uniQure NV for a serious blood condition.
Through the acquisition, Pfizer will gain access to Bamboo's experimental gene therapies for rare diseases such as Duchenne Muscular Dystrophy (DMD), giant axonal neuropathy (GAN), Friedreich ataxia (FA) and Canavan disease.
Boeing's website describes their efforts as such: "Boeing is helping guide the industry toward supporting the development and commercialization of a new generation of sustainable, plant-based fuel sources that offer a lower lifecycle carbon footprint and don't compete with food and land resources. These advanced-generation sustainable biofuels afford significant environmental benefits when considered on a lifecycle basis."
The agreement was marred, however, in May when the Tehran museum director Majid Mollanoroozi handed out an award for an antisemitic cartoon about the Holocaust, sparking protests from Israel and Germany.
Research into gene therapy, which aims to insert corrective genes into malfunctioning cells, goes back a quarter of a century but the field has experienced multiple setbacks and been plagued by safety concerns.
Other big drugmakers have made similar investments. Bristol-Myers Squibb Co has a tie-up with uniQure to develop gene therapies for heart diseases, while Celgene Corp has teamed up with bluebird bio Inc for cancer. (Reporting by Natalie Grover in Bengaluru; Editing by Maju Samuel)
The Prussian Cultural Heritage Foundation (SPK), which manages Berlin's main museums, said it had agreed a deal with the Tehran Museum of Contemporary Art for a major exhibition of the collection in the German capital from December until February next year.
But controversy flared after the Tehran museum chief this year handed out an award for a Holocaust cartoon, and the loan project was reportedly further complicated by fears in the Islamic republic about legal claims if the pictures travel abroad.
